Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nolpitantium Besylate in Patients With Mild to Moderate Ulcerative Colitis, a Double-Blind, Placebo Controlled Efficacy and Safety, 8 Week Study

NCT00232258 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00232258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00232258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nolpitantium Besylate in Patients With Mild to Moderate Ulcerative Colitis, a Double-Blind, Placebo Controlled Efficacy and Safety, 8 Week Study
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
September 30, 2006
Enrollment
307 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease, ulcerative colitis